Trump Order Creates an NIH Women’s Health Division and a Task Force, but Brings No New Money
ANALYSIS · October 20, 2026
Slug: advancing-womens-health-improve-outcomes-all-phases
Package note: This Analysis covers the executive order “Advancing Women’s Health to Improve Outcomes in All Phases of Life,” signed October 19, 2026. It orders NIH to set up a Women’s Health Division within 90 days, creates a White House Women’s Health Task Force, and revokes two Biden-era actions. Every claim below is checked against the order’s text.
Primary sources
- The White House, “Advancing Women’s Health to Improve Outcomes in All Phases of Life” (Executive Order, October 19, 2026): https://www.whitehouse.gov/presidential-actions/2026/10/advancing-womens-health-to-improve-outcomes-in-all-phases-of-life
The order says many conditions that “disproportionately or uniquely affect women” have not received the research and clinical attention other conditions have. It directs the HHS Secretary, through the NIH Director, to “establish a Women’s Health Division within an appropriate institute or center within 90 days.” It creates a White House Women’s Health Task Force co-chaired by the HHS Secretary and the White House Chief of Staff. It revokes Executive Order 14120 of March 18, 2024, and the Presidential Memorandum of November 13, 2023, which set up the previous administration’s women’s health research initiative.
Core Tension
The order promises “bolstered scientific investment” but contains no dollar figure. It is to be carried out “subject to the availability of appropriations,” and it “does not, create any right or benefit… enforceable at law.” It doesn’t name which NIH institute will house the new division, and it sets no research targets or budget. The only deadline is the 90 days to set up the division. It also works alongside the existing NIH Office of Research on Women’s Health rather than replacing it, and the order doesn’t explain how the two will divide the work. Its main concrete act is replacing the Biden-era structure with a new one under this administration.
What the order does
| Section | Text / effect |
|---|---|
| Sec. 1 | Sets the policy “to prioritize translating research into improved clinical care that benefits women and girls” from infancy through aging. Lists conditions needing more research, including heart disease, cancer, stroke, Alzheimer’s, autoimmune conditions, osteoporosis, endometriosis, fibroids, infertility, maternal health and menopause. |
| Sec. 2 | NIH must set up a Women’s Health Division “within 90 days,” working with the NIH Office of Research on Women’s Health. Its duties include more scientific review of understudied conditions, replication studies, more inclusion of women and girls in clinical trials, and “accountability for grant recipients” on NIH’s sex-as-a-biological-variable policy. |
| Sec. 3 | Creates the Task Force, co-chaired by the HHS Secretary and the Chief of Staff. Its 11 named members are the Secretaries of War, Agriculture, Labor, Education and Veterans Affairs; the EPA Administrator; the FDA Commissioner; and the CDC, NIH, ARPA-H and CMS heads. The Co-Chairs can invite others. HHS pays its administrative costs. |
| Sec. 4 | The Task Force focuses on research, getting findings into clinical practice, patient-centered care, and consulting states, tribes, faith-based groups, industry and others. It “may” advise agencies on pilot programs, “as deemed appropriate by the agency head and consistent with applicable law.” |
| Sec. 5 | Revokes EO 14120 (March 18, 2024) and the Presidential Memorandum of November 13, 2023. |
| Sec. 6 | Standard provisions: implemented “subject to the availability of appropriations”; creates no enforceable right or benefit. |
Claims check
| Claim | Assessment | Basis |
|---|---|---|
| The order creates a Women’s Health Division at NIH | Ordered, not yet created | Sec. 2(a) gives 90 days; no institute named |
| The order creates a White House task force | Verified | Sec. 3(a) |
| The order revokes two Biden-era actions | Verified | Sec. 5(a)–(b) |
| The order brings “bolstered scientific investment” | Not supported by the text | No funding amount; Sec. 6(b) ties everything to existing appropriations |
| The order creates new rights for patients | False | Sec. 6(c) |
Context / what to watch
- About January 17, 2027: the 90-day deadline for NIH to set up the division, and which institute or center houses it.
- Budget: whether the FY2027 request or appropriations give the division its own funding.
- Office of Research on Women’s Health: whether its role or budget changes once the new division exists.
- Task Force output: the order sets no deadline for meetings, hearings or recommendations.
Publish-ready ANALYSIS · written by KVOp from the whitehouse.gov order · 2026-10-20 · for /analysis/advancing-womens-health-improve-outcomes-all-phases